Torrent Pharmaceuticals Ltd. benchmarking: Performance to industry peers

Financial

	Torrent Pharma	Cipla	Dr. Reddy's Labs.
Operational Metrics
Pharmaceuticals
Number of ANDA's Filed in USA	174.0 .	285.0 .	376.0 .
Number of ANDA's Approved By USFDA	132.0 .	230.0 .	301.0 .
Domestic Sales Growth - YoY	11.6 %	7.7 %	11.3 %
R&D as a % of Total Sales	4.0 %	7.8 %	7.3 %
Financials
5 yr Average ROE	21.66 %	13.53 %	15.68 %
5yr average Equity Multiplier	2.73	1.22	1.42
5yr Average Asset Turnover Ratio	0.64	0.77	0.71
5yr Avg Net Profit Margin	13.92 %	14.55 %	15.62 %
Price to Book	19.23	3.42	3.03
P/E	74.55	30.37	27.34
5yr Avg Cash Conversion Cycle	-145.98 Days	-6.65 Days	98.95 Days
Inventory Days	53.66 Days	57.59 Days	76.71 Days
Days Receivable	45.41 Days	52.05 Days	103.79 Days
Days Payable	270.49 Days	107.59 Days	99.52 Days
5yr Average Interest Coverage Ratio	8.01	68.84	32.6
5yr Avg ROCE	23.39 %	19.16 %	21.4 %
5yr Avg Operating Profit Margin	30.55 %	22.76 %	23.38 %
5 yr average Debt to Equity	0.85	0.02	0.13
5yr CAGR Net Profit	22.72 %	9.04 %	13.97 %
5yr Average Return on Assets	8.89 %	11.12 %	11.22 %
Shareholdings
Promoter Holding	68.31 %	29.21 %	26.63 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-2.94 %	-4.34 %	-0.07 %
Change in Mutual Fund Holding (3 Yrs)	-1.92 %	3.66 %	3.32 %

Business

	Torrent Pharma	Cipla	Dr. Reddy's Labs.
Product Wise Break-Up	Product Wise Break-Up Domestic Formulations 42.15 US Formulations 20.71 Germany 13.15 Brazil 8.98 Contract Manufacturing 6.15 New ventures 0 Pharmaceuticals 0 Proprietary Products 0 Global Generics 0 0 Others 8.86	Product Wise Break-Up Germany 0 Domestic Formulations 0 Pharmaceutical 94.65 0 Contract Manufacturing 0 New ventures 5.35 US Formulations 0 Brazil 0 Proprietary Products 0 Global Generics 0	Product Wise Break-Up Germany 0 Domestic Formulations 0 Pharmaceuticals 0 Pharmaceutical 14.36 Contract Manufacturing 0 New ventures 0 US Formulations 0 Brazil 0 Proprietary 0.31 Formulations 85.33
Location Wise Break-Up	Location Wise Break-Up India 64.69 Brazil 13.29 USA 11.57 Germany 9.73 SAGA 0 Europe 0 Global API 0 Rest of the World 0 Emerging Markets 0 North America 0 Russia 0 Others 0.72	Location Wise Break-Up Rest of the World 0 Europe 12.0 Germany 0 USA 0 Russia 0 India 46.0 Emerging Markets 0 Brazil 0 North America 22.0 Global API 1.0 SAGA 19.0	Location Wise Break-Up Rest of the World 0 Europe 0 Germany 0 USA 48.56 Russia 7.99 India 17.36 Emerging Markets 0 Brazil 0 North America 0 Global API 0 SAGA 0 Others 26.09
Acute vs Chronic	Acute vs Chronic Chronic 76.0 Acute 24.0 Sub - chronic 0	-	-
Therapeutic Area Break-Up	Therapeutic Area Break-Up Cardiac Science 25.0 Gastro Intestinal 17.0 CNS 15.0 VMN 11.0 Anti - Diabetes 10.0 Pain Management 7.0 Gynecology 2.0 Anti-Infective 2.0 Rest 2.0 Respiratory 0 Anti-Infective 0 Central Nervous System 0 Pain Management 0 Cardiovascular 0 Oncology 0 Gastrointestinal 0 Others 9.0	-	Therapeutic Area Break-Up Pain Management 9.77 Anti-Infective 6.48 Central Nervous System (CNS) 12.12 Cardiac Science 0 CNS 0 Cardiac Science 6.65 Oncology 27.53 Gynecology 0 Rest 0 Anti - Diabetes 0 Gastro Intestinal 9.52 Respiratory 7.04 Gastro Intestinal 0 VMN 0 Others 20.89
Asset Break-Up	Asset Break-Up India 94.39 USA 0.46 South Africa 0 United States 0 Switzerland 0 Others 5.15	Asset Break-Up Switzerland 0 USA 28.99 South Africa 18.03 United States 0 India 49.7 Others 3.28	Asset Break-Up Switzerland 8.45 USA 0 South Africa 0 USA 2.37 India 80.24 Others 8.94

Torrent Pharmaceuticals Ltd.

Torrent Pharmaceuticals Ltd.

Financial

Business

SIGN UP FOR FREE